HeraMED’s digital maternity care platform HeraCARE logs record user growth
Digital maternity care specialist HeraMED (ASX: HMD) continues to attract strong support for its unique HeraCARE platform.
The end-to-end digital maternity monitoring and management platform has reached a record number of accumulated users, with further strong growth forecast.
According to HeraMED, the number registered on the HeraCARE platform as of 15 June 2024 reached 3,533—representing sequential growth of 12% or 365 users since 31 March 2023.
Partnerships driving growth
The company expects the number of accumulated HeraCARE platform users to continue to grow, supported by a number of previously announced agreements and partnerships.
These include e-Lovu Health, which is targeting private clinics on the US west coast.
e-Lovu has recorded steady growth with 15 clinics now using HeraCARE and 345 current active users on the platform across all clinics.
Perth-based private clinics Simply Women and JOGG have also begun to increase the number HeraCARE users, with 153 active at last count.
Remote monitoring
HeraCARE provides remote pregnancy monitoring for patients with customised care plans focused on low-risk pregnancies, as well as those with hypertension, gestational diabetes and mental health issues including post-partum care.
HeraMED believes that with increasing deployment, the accumulated data is expected to deliver significant revenue, product and patient opportunities, along with continued innovation such as HeraMED’s “data as a service” approach.
Approximately 90,000 digital measurements have so far been recorded from the 3,533 pregnancies managed through HeraCARE.
This includes fetal and maternal heart rates, blood pressure, weight, temperature and mood tracking.
Valuable data
The accumulated data is eventually expected to provide early clinical intervention opportunities and a reduction of mortality and morbidity.
“We continue to execute on our recently announced four-point strategic plan,” managing director and chief executive officer Anoushka Gungadin said.
“The strong operating momentum and feedback from customers and health providers is translating into rapid accumulated user growth on our HeraCARE platform.”
“In driving our data-as-an-asset strategy, we are building quality as well as quantity of data.”
“High-quality data ensures accurate diagnosis and treatment, while sufficient quantity provides a comprehensive view of the patient’s health, enabling more informed decision-making.”
Focused maternity care
According to studies undertaken by the University of Technology Sydney, the cost of maternity care is rising while adverse birth outcomes have also become more frequent.
Their report found that as health care spending changes in the wake of the COVID pandemic, care that is tailored to the needs of patients and communities is essential for maintaining quality and equity in maternity care.
It was also found that growing rates of intervention during pregnancy align with projections for 2030 that 45% of births in Australia and New Zealand will be by caesarean delivery.